期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

软组织肉瘤分子遗传学研究进展 被引量：1

下载PDF
导出
摘要 软组织肉瘤是间叶源性恶性肿瘤,有其独特的细胞遗传学改变,根据肿瘤细胞遗传学特点可分为两大类:一类有着特殊的遗传学改变且核型简单;另一类则缺乏特殊遗传学改变但常常有着复杂的核型,这两类肿瘤在分子发生机制、治疗和预后方面均有所不同,因此了解和掌握其分子生物学改变对于肿瘤的诊治和预后具有重要意义。
作者 刘春霞 李锋
机构地区 新疆石河子大学医学院病理学系
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2012年第3期305-308,共4页 Chinese Journal of Clinical and Experimental Pathology
基金 国家自然科学基金(81160322)
关键词 软组织肉瘤 分子遗传学 染色体 易位
分类号 R738.6 [医药卫生—肿瘤]
  • 相关文献

参考文献25

  • 1王正,范钦和.横纹肌肉瘤分子病理学研究进展[J].临床与实验病理学杂志,2007,23(4):477-479. 被引量：14
  • 2LI Q X,LIU C X,Li F,et al.Comparative genomic hybridization:the profile of chromosomal imbalances in rhabdomyosarcoma[J].Chin Med J,2009,122(11):1277-82.
  • 3Savola S,Klami A,Tripathi A,et al.Combined use of expression and CGH arrays pinpoints novel candidate genes in Ewing sarcoma family of tumors[J].BMC Cancer,2009,9:17.
  • 4Nakagawa Y,Numoto K,Yeshida A,et al.Chromosomal and genetic imbalances in synovial sarcoma detected by conventional and mieroarray comparative genomic hybridization[J].J Cancer Res Clin Oncol,2006,132(7):444-50.
  • 5Kaur S,Vauhkonen H,Bhling T,et al.Gene copy number changes in dermatofibrosarcoma protuberans:a fine-resolution study using array comparative genomic hybridization[J].Cytogenet Genome Res,2006,115(3-4):283-8.
  • 6Meza-Zepeda L A,Kresse S H,Barragan-Polania A H,et al.Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomas[J].Cancer Res,2006,66(18):8984-93.
  • 7Lasota J,Wozniak A,Kopczynski J,et al.Loss of heterozygosity on chromosome 22q in gastrointestinal stromal tumors (GISTs):a study on 50 cases[J].Lab Invest,2005,85(2):237-47.
  • 8Yang J,Du X,Chen K,et al.Genetic aberrations in soft tissue leiomyosarcoma[J].Cancer Lett,2009,275(1):1-8.
  • 9Hu J,Rao U N,Jasani S,et al.Loss of DNA copy number of 10q is associated with aggressive behavior of leiomyosarcomas:a comparative genomic hybridization study[J].Cancer Genet Cytogenet,2005,161(1):20-7.
  • 10Adamowicz M,Radlwimmer B,Rieker R J,et al.Frequent amplifications and abundant expression of TRIO,NKD2,and IRX2 in soft tissue sarcomas[J].Genes Chromosomes Cancer,2006,45(9):829-38.

二级参考文献54

  • 1Chang B,Pang L J,Li F.PAX-FKHR fusion genes and AChR-γ in Chinese patients with rhabdomyosarcoma:diagnosis using formalin-fixed archival tissues[J].Int J Surg Pathol,2009,17(1):6-15.
  • 2Wang H,Garzon R,Sun H,et al.NF-kB-YY1 miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma[J].Cancer Cell,2008,14(5):369-81.
  • 3Ciarapica R,Russo G,Verginelli F,et al.Deregulated expression of miR-26a and Ezh2 in rhabdomyosarcoma[J].Cell Cycle,2009,8(1):172-5.
  • 4Missiaglia E,Shepherd C J,Patel S,et al.MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas[J].Br J Cancer,2010,102(12):1769-77.
  • 5Paulino A C,Okcu M F.Rhabdomyosarcoma[J].Curr Probl Cancer,2008,32(1):7-34.
  • 6Ognjanovic S,Linabery A M,Charbonneau B,Ross J A.Trends in childhood rhabdomyosarcoma incidence and survival in the United States,1975-2005[J].Cancer,2009,115(18):4218-26.
  • 7Mercado G E,Barr F G.Fusions involving PAX and FOX genes in the molecular pathogenesis of alveolar rhabdomyosarcoma:recent advances[J].Curr Mol Med,2007,7(1):47-61.
  • 8Davicioni E,Anderson M J,Finckenstein F G,et al.Molecular classification of rhabdomyosarcoma-genotypic and phenotypic determinants of diagnosis:a report from the Children′s Oncology Group[J].Am J Pathol,2009,174(2):550-64.
  • 9Wachtel M,Dettling M,Koscielniak E,et al.Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1[J].Cancer Res,2004,64(16):5539-45.
  • 10Hosoi H,Kakazu N,Konishi E,et al.A novel PAX3 rearrangement in embryonal rhabdomyosarcoma[J].Cancer Genet Cytogenet,2009,189(2):98-104.

共引文献29

同被引文献24

  • 1Acevedo V D, Gangula R D, Freeman K W, et al. Inducible FG- FR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition [ J]. Cancer Cell, 2007, 12(6) :559 -71.
  • 2Ohean S, Sorg B S, Albrecht T, et al. Alternative inclusion offi- broblast growth factor receptor 2 exon IIIc in Dunning prostate tumors reveals unexpected epithelial mesenchymal plasticity [ J ]. Proc Natl Acad Sci USA, 2006,103 (38) : 14116 - 21.
  • 3Hart K C, Robertson S C, Kanemitsu M Y, et al. Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4 [ J ]. Oncogene, 2000,19 ( 29 ) :3309 - 20.
  • 4Stratton M R, Campbell P J, Futreal P A. The cancer genome [J]. Nature, 2009,458(7239):719 -24.
  • 5Stavridis M P, Lunn J S, Collins B J, et al. A discrete period of FGF-induced Erkl/2 signalling is required for vertebrate neural specification[ J. Development, 2007,134 (16) :2889 - 94.
  • 6Goldstein M, Meller I, Orr-Urtreger A. FGFR1 over-expression in primary rhabdomyosarcoma tumors is associated with hypomethyla- tion of a 5' CpG island and abnormal expression of the AKT1, NOG, and BMP4 genes[J]. Genes Chromosomes Cancer, 2007, 46(11) :1028 -38.
  • 7Forough R, Weylie B, Patel C, et al. Role of AKT/PKB signaling in fibroblast growth factor-1 ( FGF-1 ) -induced angiogenesis in the chicken chorioallantoic membrane ( CAM ) [ J ]. J Cell Biochem, 2005,94( 1 ) : 109 - 16.
  • 8Koziezak M, Holbro T, Hynes N E. Blocking of FGFR signaling inhibits breast cancer cell proliferation through downregulation of D-type cyclins[ J ]. Oncogene, 2004,23 (20) :3501 - 8.
  • 9Hart K C, Robertson S C, Kanemitsu M Y, et al. Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4 [ J. Oncogene, 2000,19 (29) :3309 - 20.
  • 10Carmo C R, Lyons-Lewis J, Seckl M J, et al. A novel requirement for Janus kinases as mediators of drug resistance induced by fibro- blast growth factor-2 in human cancer ceils [ J ]. PLoS One, 2011,6(5) :1371 -9.

引证文献1

临床与实验病理学杂志
2012年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部